293 related articles for article (PubMed ID: 22841774)
1. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.
Yu W; Chai H; Li Y; Zhao H; Xie X; Zheng H; Wang C; Wang X; Yang G; Cai X; Falck JR; Yang J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):73-83. PubMed ID: 22841774
[TBL] [Abstract][Full Text] [Related]
2. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
3. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J
Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482
[TBL] [Abstract][Full Text] [Related]
5. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
6. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells.
Liu GT; Chen HT; Tsou HK; Tan TW; Fong YC; Chen PC; Yang WH; Wang SW; Chen JC; Tang CH
Oncotarget; 2014 Nov; 5(21):10718-31. PubMed ID: 25301739
[TBL] [Abstract][Full Text] [Related]
7. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
8. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
10. HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1.
Liu H; Qin H; Zhou Y; Yuan Y; Liu Y; Chen Y; Yang Y; Ni H; Xi T; Zheng L
Mol Carcinog; 2021 Jun; 60(6):413-426. PubMed ID: 33866606
[TBL] [Abstract][Full Text] [Related]
11. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Chetty C; Lakka SS; Bhoopathi P; Kunigal S; Geiss R; Rao JS
Cancer Res; 2008 Jun; 68(12):4736-45. PubMed ID: 18559520
[TBL] [Abstract][Full Text] [Related]
13. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERK‑mediated VEGF‑VEGFR2 signaling pathway.
Li CH; Sun XJ; Niu SS; Yang CY; Hao YP; Kou JT; Li XZ; Wang XX
Oncol Rep; 2018 Sep; 40(3):1795-1802. PubMed ID: 30015941
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
16. Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in
McDonald MG; Ray S; Amorosi CJ; Sitko KA; Kowalski JP; Paco L; Nath A; Gallis B; Totah RA; Dunham MJ; Fowler DM; Rettie AE
Drug Metab Dispos; 2017 Dec; 45(12):1364-1371. PubMed ID: 29018033
[TBL] [Abstract][Full Text] [Related]
17. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription.
Fernández JG; Rodríguez DA; Valenzuela M; Calderon C; Urzúa U; Munroe D; Rosas C; Lemus D; Díaz N; Wright MC; Leyton L; Tapia JC; Quest AF
Mol Cancer; 2014 Sep; 13():209. PubMed ID: 25204429
[TBL] [Abstract][Full Text] [Related]
18. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
19. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
